Insider sale
DYNE THERAPEUTICS, INC.
$5.84M
253.04K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 253.04K shares of DYNE THERAPEUTICS, INC. valued at approximately $5.84M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/6/2026ACC: 0001628280-26-047357
10% Owner
Since Sep 2020
253.04K
Shares to sell
$5.84M
Approx. market value
253.04K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
253.04KTotal acquired253.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 253.04K | — |
| Total | 253.04K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
253.04K
Market value
$5.84M
7/6/2026
Total
Units
253.04K
Value
$5.84M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/6/2026 | 253.04K | $5.84M | Nasdaq | Planned |
| Total | 253.04K | $5.84M | ||